In our results, all HER2 12-bp duplicated insertions were categorized as ADC (2.0%, n = 446), and the mutations were not found in any other lung cancer type tested (SCC, AS, SCLC and LCNEC). This evidence concerns the gene ERBB2 and large cell neuroendocrine carcinoma.